UNC alum, pharmaceutical exec Fred Eshelman makes another investment: experimental cancer treatment

Posted Apr 28, 2015
Fred Eshelman made another move by joining a group that invested $28 million in Innocrin Pharmaceuticals, a company developing treatments for breast and prostate cancers. Eshelman, who recently founded Eshelman Ventures, also joined Innocrin's board. (Triangle Business Journal)

Related: Campus Connections

Highlights of 2024 at Carolina
In 2024, Carolina celebrated research milestones, remarkable centennials, national championships and more. The year began with Lee H. Roberts arriving in Chapel Hill as interim...
Mon Dec 23, 2024

Carolina celebrates the Class of 2024 at winter commencement
After years of hard work — whether it be class readings, group projects, student group activities, papers, late nights studying or exams — graduating UNC...
Sun Dec 22, 2024

A playlist of Chapel Hill-themed holiday songs
Joni Mitchell went Christmas caroling in the Morgan Creek neighborhood in December 1970 with her then boyfriend, James Taylor. Six months later, Mitchell’s album Blue...
Fri Dec 20, 2024

Video: New UNC Football coach Bill Belichick brings in big business for stores in Chapel Hill
Many Franklin Street businesses in Chapel Hill are reaping the benefits, following the news that Bill Belichick, one of the greatest NFL coaches of all...
Tue Dec 17, 2024